|
|
| | PGDM-d4 Basic information |
| Product Name: | PGDM-d4 | | Synonyms: | PGDM-d4 | | CAS: | | | MF: | C16H20D4O7 | | MW: | 332.382207112 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | PGDM-d4 Chemical Properties |
| solubility | DMF: 50 mg/ml
DMSO: 50 mg/ml
Ethanol: 50 mg/mlPBS (pH 7.2): 1 mg/ml |
| | PGDM-d4 Usage And Synthesis |
| Description | PGDM-d4 is intended for use as an internal standard for the quantification of PGDM by GC- or LC-MS. PGD2 plays a pharmacological role in allergic and asthmatic anaphylaxis, normal physiological sleep and lowering of body temperature, as well as inhibits platelet aggregation and relaxes vascular smooth muscle.1 PGDM is a major urinary metabolite of PGD2 with a unique lower sidechain that readily undergoes reversible cyclization.2 It is used as a biomarker to assess endogenous production of PGD2.WARNING This product is not for human or veterinary use. | | References | [1] H. GILES P. L. The biology and pharmacology of PGD2[J]. Prostaglandins, 1988, 35 2: Pages 277-300. DOI: 10.1016/0090-6980(88)90093-7
[2] JASON D. MORROW. Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assay[J]. Analytical biochemistry, 1991, 193 1: Pages 142-148. DOI: 10.1016/0003-2697(91)90054-w |
| | PGDM-d4 Preparation Products And Raw materials |
|
|
Tag:PGDM-d4
Related Product Information
|
|
tetranor-PGDM lactone-d6
Prosta-5,13-dien-1-oic-17,17,18,18,19,19,20,20,20-d9 acid, 9,15-dihydroxy-11-oxo-, (5Z,9α,13E,15S)-
tetranor-PGDM lactone
9alpha,15S-dihydroxy-11-oxo-prosta-5z,13e-dien-1-oic-3,3,4,4-d4 acid
15-deoxy-Δ12,14-Prostaglandin D2-d4
|